Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TransMedics (TMDX) Other financing activities (2019 - 2025)

TransMedics (TMDX) has 3 years of Other financing activities data on record, last reported at $138000.0 in Q3 2025.

  • For Q3 2025, Other financing activities changed N/A year-over-year to $138000.0; the TTM value through Sep 2025 reached $723000.0, changed N/A, while the annual FY2020 figure was $705000.0, 85.45% down from the prior year.
  • Other financing activities reached $138000.0 in Q3 2025 per TMDX's latest filing, down from $366000.0 in the prior quarter.
  • Across five years, Other financing activities topped out at $138000.0 in Q3 2025 and bottomed at $138000.0 in Q3 2025.